The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
United States
251-500 Employees
1983
At RNA Corporation, our mission is to help create innovative products that lead to success for our brand partners. We provide our full commitment to our partners regardless of size. We are experts in the hair care product field with decades of experience making shampoos, conditioners, styling gels, cowashes, leave in conditioners, deep treatment masks and hair serums. We are an extension of your team.The best partnerships happen when both sides have information to make the best decisions. We believe all customers are entitled to the best quality products possible, and therefore commit ourselves to adhering to strict formulation guidelines, regulatory requirements, and continuous process improvement. We also believe that innovation is the key to greatness and brand differentiation, which is why we continuously strive to create new formulas across multiple categories such as hair care, skin care, and OTC topical drugs. RNA Corporation is a full service turnkey contract manufacturer helping brands create amazing and innovative personal care products. We handle all the behind-the-scenes work including concept ideation, testing, manufacturing, packaging, and fulfillment allowing our partners to focus on innovation, marketing, sales, and their customers.
+
Featured
Testing - RNA Services
... Testing - RNA ...
Calgary, Canada
11-50 Employees
We are a Canadian Contract Development and Manufacturing Organization (CDMO) focused on End-to-End Supply of Nucleic Acid Products. Our offerings include Research, GMP-Start, cGMP grade manufacturing of cap analogs, cell banks, plasmid DNA, mRNA and more. We specialize in the production of nucleic acid products that support life-enabling work. We support our clients by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field.
+
Featured
Analytical & Stability Testing | Northern RNA
... Analytical & Stability Testing | Northern RNA ...
London, United Kingdom
1-10 Employees
2020
Delivering the most advanced and integrated bio-digital system for COVID-19 status management.
+
Featured
Our Solutions – Making travel safe again
... LAMP (RNA) Testing (Icgene) ...
Lower Moreland Township, United States
1-10 Employees
2018
At Contamination Source Identification (CSI), our mission is to contribute meaningfully to the delivery of effective patient care by providing physicians with accurate active pathogen identification results to enable confident disease diagnosis and targeted treatment decisions. CSI is a privately owned company, and owns 100% of their Intellectual property, including patents. At Contamination Source Identification (CSI), our mission is to contribute meaningfully to the delivery of effective patient care.
+
Featured
Applied Research | Contamination Source Identification
... See how the same RNA-based infection testing has been used to identify bacteria, virus, and fungal species in varied applications. ...
Hillsboro, United States
1-10 Employees
2016
We are proud to announce that MVL is now majority owned and supported by Centrillion Biosciences, a biotechnology company based in Palo Alto, California. We are clinicians, scientists and business professionals who aim to provide unparalleled service to our customers. Our mission is to harness the potential of genomics to improve patient care by developing market-leading tests at competitive prices. We are majority owned and supported by Centrillion Technologies, a Palo Alto, CA-based company that aspires to complete the work of the Human Genome Project and help scientists efficiently characterize and analyze large segments of the genome to power previously unimaginable breakthroughs in human health and the environment. Molecular Vision (MVL) is a CAP and CLIA-certified medical diagnostic laboratory that provides state-of-the-art genetic testing for clients worldwide.
+
Featured
Molecular Vision Lab | Genetic Testing for Eye Diseases & COVID-19 Saliva RNA Testing
... Molecular Vision Lab | Genetic Testing for Eye Diseases & COVID-19 Saliva RNA Testing ...
1-10 Employees
Ensure your manufacture and production are up to standards for consumables used in molecular biology and diagnostic markets. ARYTE Bioscience has over 20 years of experience in guiding and revamping: facilities, personnel, and systems to be able to meet the stringent needs of the molecular and microbiological market. Establish and monitor sterilization claims for medical devices and products.
+
Featured
RNase Free Certification | ARYTE Bioscience
... RNase Free, DNase Free, DNA Free, RNA Free Certification Testing. Sterility and Dose Audit Testing. ARYTE Bioscience is an independent 3rd Party Testing Lab with over 20 years in laboratory consumables and medical devices. ...
Eindhoven, Netherlands
11-50 Employees
2022
The InnoSIGN team is committed to transform cancer care by enabling personalized targeted therapy options through OncoSIGNal pathway activity profiling. Our team has a wealth of experience in bringing innovative diagnostic solutions to the market.
+
Featured
G7 - InnoSIGN
... Add PCR mix with extracted RNA to testing ...
Pune, India
51-100 Employees
2014
Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation. Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ offers (B2B) market research reports such as syndicated market research reports, custom….
+
Featured
Life Science Reagents Market Report
... , Molecular Diagnostic), By Application (Protein Synthesis & Purification, Gene Expression, DNA & RNA Analysis, Drug Testing) By End - User (Academic and Research Institutes, Commercial and Contract Research Manufacturers, Hospitals & Diagnostic Laboratories) and Geography - Global ...
Solna kommun, Sweden
51-100 Employees
2004
The Science & SciLifeLab Prize for Young Scientists is a global prize, established in 2013, aimed at rewarding scientists at an early stage of their careers. Science/AAAS and SciLifeLab, a coordinated effort of four universities, have joined forces in creating the Science & SciLifeLab Prize for Young Scientists to recognize excellence amongst young researchers from around the world. A number of research constellations and initiatives makes up our scientific community, such as the more than 200 affiliated academic research groups, the SciLifeLab Fellows program, Data-driven life science, and lately also a national research program targeting Covid-19. Our units provide access to the latest biomolecular technologies and expertise to bring research projects to the next level, whilst researchers using our services can team up with our dedicated staff scientists to propel technology development and really push the limit of what is possible in life science. This is a practical course on sample preparation for TEM and includes: Participants will practice TEM sample preparation and TEM imaging with a sample from their own project.
+
Featured
Diagnostics for virus - SciLifeLab
... Diagnostics for virus This research area aims at developing alternative viral RNA diagnostics by: Establishing testing capacity using alternative technologies to that used in the main testing program, as backup […] ...
San Diego, United States
101-250 Employees
2013
We are proud of our growing collaborations with partners that include premier academic research institutions, emerging start-ups to nearly all of the Top 25 Biopharma companies. With our breakthrough automation solutions for biological synthesis and expertise in DNA biology, we enable rapid, accurate, and reproducible writing of DNA and mRNA for wide-ranging biological applications. Telesis Bio is committed to best practices in biosecurity and is a member of the International Gene Synthesis Consortium. The expertise of our scientists, engineers and supporting teams are at your service! Experience up to 20x increases in productivity to your product development cycles. From gene synthesis through complex whole synthetic genome construction, our BioXp biofoundry services provide the speed and accuracy of the BioXp system with Gibson Assembly technology, the most trusted method for building seamless, high-fidelity DNA.
+
Featured
Coronavirus - Telesis Bio
... "I ordered gene fragments on the BioXp™ reagent ordering portal, completed construction of five vaccine candidates against SARS-CoV-2, sequence-verified, manufactured RNA for animal testing, and immunized mice in just eight days." ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for RNA Testing
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 6 |
| Amount of suitable service providers | 7 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1983 |
| Youngest suiting company | 2022 |
20%
40%
60%
80%
RNA testing involves the analysis of ribonucleic acid (RNA) sequences within cells to identify and quantify gene expression, viruses, or mutations. This form of testing is pivotal in the realms of molecular biology and genetics, offering a window into the cellular functions and regulatory mechanisms at play. By isolating RNA, scientists can understand how genes are expressed in different types of cells and under various conditions, providing insights into disease mechanisms, developmental processes, and the effects of environmental factors on gene expression. In the context of virology, RNA testing is instrumental for the detection and quantification of RNA viruses, such as the novel coronavirus, enabling rapid diagnosis and monitoring of viral loads in patients. This technology underpins the development of targeted therapies and vaccines by allowing researchers to observe the impact of genetic mutations and the response to treatments at a molecular level. The versatility and sensitivity of RNA testing make it a cornerstone in personalized medicine, where it aids in tailoring treatments to the genetic makeup of individual patients, significantly enhancing the efficacy and reducing the side effects of therapies. Overall, RNA testing's role extends beyond mere diagnostics; it is a fundamental tool in advancing our understanding of genetics, disease progression, and the interaction between genes and the environment, marking a significant impact on both research and clinical practice.
1. Sensitivity and Specificity
RNA testing stands out for its high sensitivity and specificity, enabling the detection of diseases at very early stages. Unlike some DNA tests, RNA tests can identify active infections by detecting the presence of the virus's genetic material, offering timely insights critical for effective treatment and prevention strategies.
2. Speed of Results
Another significant advantage of RNA testing is the rapid turnaround time for results. This fast processing is crucial in clinical settings where time is of the essence, such as during outbreaks of infectious diseases. Quick results allow for immediate action, potentially saving lives by enabling quicker isolation and treatment protocols.
3. Monitoring Disease Progression
RNA testing is invaluable for monitoring the progression of diseases. Since RNA levels can reflect how actively a virus is replicating, these tests provide insights into the severity of an infection and how it changes over time. This information is essential for tailoring treatment plans to individual needs, enhancing the chances of recovery.
4. Adaptability to Emerging Pathogens
Due to its nature, RNA testing can be quickly adapted to identify new pathogens. As diseases evolve, RNA tests can be developed or modified with relative ease to detect novel viruses, ensuring that healthcare providers remain equipped to respond to emerging health threats.
While evaluating the different suppliers make sure to check the following criteria:
1. Accreditation and Certifications
Ensure the supplier has the necessary accreditations, such as CLIA or CAP, which validate their ability to perform high-quality RNA testing.
2. Technology and Equipment
Check for the latest and most efficient technology, ensuring accurate and reliable results.
3. Experience and Expertise
The supplier should have a proven track record and expertise specifically in RNA testing to handle complex samples and interpret results accurately.
4. Turnaround Time
Evaluate the supplier's capability to deliver results within a reasonable timeframe without compromising accuracy.
5. Customer Support and Communication
Good communication and support are crucial for addressing queries and providing explanations regarding test results.
6. Cost-effectiveness
While not compromising on quality, the supplier should offer competitive pricing and value for money.
7. Data Security and Privacy
Ensure the supplier follows stringent data security protocols to protect sensitive information.
RNA testing plays a crucial role in the healthcare industry, primarily for diagnosing and monitoring viral infections. By detecting the presence of viral RNA, medical facilities can accurately identify infectious diseases like COVID-19, influenza, and hepatitis C in patients. This precision aids in implementing timely treatment protocols, significantly impacting patient outcomes and public health management. In the agricultural sector, RNA testing is instrumental for identifying plant diseases caused by RNA viruses. Farmers and agribusiness companies rely on this technology to detect infections early, enabling them to take preventive actions to safeguard crops. This early detection limits the spread of disease, ensuring the stability of food supply chains and minimizing economic losses. Pharmaceutical companies leverage RNA testing in the development of new drugs and vaccines. Through detailed analysis of RNA, researchers can understand how diseases affect gene expression, guiding the creation of targeted therapies. This application accelerates the development process, enhancing the efficacy and safety of pharmaceutical products. Environmental monitoring benefits from RNA testing by tracking the presence of pathogens in water sources. This application is essential for public health, as it helps in identifying contamination outbreaks early, allowing for swift response actions to prevent the spread of waterborne diseases. Each of these use cases illustrates the versatile applications of RNA testing across different industries, highlighting its importance in enhancing health, food security, drug development, and environmental safety.
RNA testing, a pivotal method in the diagnosis of diseases and the monitoring of treatment efficacy, currently stands at a high Technology Readiness Level (TRL), approximately TRL 8 to 9. This classification is due to its extensive validation in real-world settings and its integration into standard healthcare protocols. The technology behind RNA testing has evolved significantly, leveraging advancements in molecular biology and bioinformatics. Its high TRL is underscored by the technical maturity of reverse transcription polymerase chain reaction (RT-PCR) techniques, which enable the detection of minute quantities of RNA from various pathogens or genetic markers with high specificity and sensitivity. Furthermore, the advent of next-generation sequencing (NGS) technologies has expanded the capabilities of RNA testing, allowing for the comprehensive analysis of RNA sequences, thereby facilitating the identification of novel pathogens and the understanding of genetic expressions in diseases at an unprecedented scale. These technical milestones have been achieved through rigorous research and development efforts, coupled with extensive clinical trials that have validated the accuracy, reliability, and utility of RNA testing in a wide array of medical applications. Consequently, RNA testing's high TRL reflects its readiness and proven effectiveness in addressing contemporary diagnostic challenges.
In the Short-Term, advancements in RNA testing are expected to focus on enhancing sensitivity and specificity. Rapid developments in sequencing technologies and bioinformatics are set to improve the detection of low-abundance RNA sequences, enabling early diagnosis of diseases. This phase will likely see the integration of machine learning algorithms to interpret complex RNA data more accurately, reducing the time and cost associated with RNA testing processes. Moving into the Mid-Term, the emphasis will shift towards personalization and portability. Innovations in nanotechnology and microfluidics will facilitate the development of portable RNA testing devices, making it feasible to conduct tests outside traditional laboratory settings. These devices will offer real-time data analysis, empowering healthcare professionals and patients with immediate insights. Additionally, the rise of personalized medicine will drive the customization of RNA tests to match individual genetic profiles, enhancing the effectiveness of treatments and preventive measures. In the Long-Term, the focus will be on integration and preventive healthcare. RNA testing technologies are anticipated to merge seamlessly with other diagnostic tools, creating comprehensive platforms for health monitoring and disease prediction. The advent of wearable technology capable of continuous RNA monitoring will revolutionize preventive healthcare, allowing for early intervention in disease processes. This era will also witness significant strides in therapeutic applications, with RNA-based treatments becoming more mainstream, guided by precise and timely RNA testing.
Some interesting questions that has been asked about the results you have just received for RNA Testing
What are related technologies to RNA Testing?
Based on our calculations related technologies to RNA Testing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of RNA Testing?
Which industries are mostly working on RNA Testing?
The most represented industries which are working in RNA Testing are Health Care, Biotechnology, Science and Engineering, Consumer Goods, Data and Analytics
How does ensun find these RNA Testing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
